Denovo Dusts Down Lundbeck's Failed Alzheimer's Drug
Three Phase III Misses For Idalopirdine
The Danish group put the 5-HT6 antagonist on the shelf after three failed late-stage trials but Denovo believes that idalopirdine could still work for a subset of Alzheimer's patients.
